A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
Ringdén
O
O
Bone Marrow Transplant Unit, Huddinge Hospital, Helsinki University Hospital, Sweden.
Ruutu
T
T
Remberger
M
M
Nikoskelainen
J
J
Volin
L
L
Vindeløv
L
L
Parkkali
T
T
Lenhoff
S
S
Sallerfors
B
B
Ljungman
P
P
D016026:Bone Marrow Transplantation / Q000276:immunology*; D002066:Busulfan / Q000627:therapeutic use* / Q000633:toxicity; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation
D003520:Cyclophosphamide; D002066:Busulfan